Non Animal Testing Database
EnglischDeutsch

T cell cytotoxicity in severe COVID-19

December 2021
Charité – Universitätsmedizin Berlin, Berlin, Germany
Severe COVID-19 is linked to both dysfunctional immune response and unrestrained immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, the researchers combined single-cell transcriptomics and single-cell proteomics with mechanistic studies to assess pathogenic T cell functions and inducing signals. They identified highly activated CD16+ T cells with increased cytotoxic functions in severe COVID-19. These cells from COVID-19 patients promoted microvascular endothelial cell injury and persisted beyond acute disease maintaining their cytotoxic phenotype. Proportions of activated CD16+ T cells and plasma levels of complement proteins upstream of C3a were associated with the fatal outcome of COVID-19, supporting a pathological role of exacerbated cytotoxicity and complement activation in COVID-19.
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
Birgit Sawitzki
#1382
Added on: 03-16-2022
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!